Akihito Kawazoe

National Cancer Center Hospital East — Japan

Medicine · Health Sciences

38h-index9.1kcitations376works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastric Cancer Management and Outcomes(143), Cancer Immunotherapy and Biomarkers(99), Colorectal Cancer Treatments and Studies(88), Gastrointestinal Tumor Research and Treatment(78), Phytochemical Studies and Bioactivities(57)

Publications375 total

Supplementary Table S4 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S4 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Table S3 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S1 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S3 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Table S2 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S2 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Figure S5 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Supplementary Table S1 from Phase I Study of the Liposomal Formulation of Eribulin (E7389-LF): Results from the Advanced Gastric Cancer Expansion Cohort
2025Open Access
Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial
ESMO Open·2025· 2 citedOpen Access
First-line pembrolizumab plus chemotherapy for participants in Japan with gastric or gastroesophageal junction adenocarcinoma: subgroup analysis of the phase 3 KEYNOTE-859 study
International Journal of Clinical Oncology·2025
Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancer
ESMO Gastrointestinal Oncology·2025· 3 citedOpen Access
<scp>ONO</scp>‐4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer
Cancer Science·2025· 1 citedOpen Access
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
New England Journal of Medicine·2025· 135 cited
Telisotuzumab adizutecan (ABBV-400; Temab-A) monotherapy vs trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer with increased c-Met protein expression: An open-label, randomized, phase 3 trial.
Journal of Clinical Oncology·2025
Supplementary Figures and Tables from The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric Cancer
2025Open Access
Circulating Tumor DNA Assessment to Predict Risk of Recurrence after Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
Annals of Surgery·2025· 3 citedOpen Access
Figure S1 from The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment
2025Open Access
Figure S6 from The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment
2025Open Access
Figure S3 from The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment
2025Open Access
page 1 of 19Next →

Frequent Co-authors

Kohei Shitara(43), Yasutoshi Kuboki(22), Takayuki Yoshino(20), Takashi Kojima(18), Toshihiko Doi(18), Takeshi Kuwata(16), Yoshiaki Nakamura(15), Daisuke Kotani(15), Shota Fukuoka(13), Hiroyoshi Nishikawa(13), Hideaki Bando(12), Yosuke Togashi(11), Saori Mishima(9), Atsushi Ohtsu(8), Yelena Y. Janjigian(7), Akinori Sasaki(6), Masashi Wakabayashi(6), Masahito Kawazu(6), Hiroyuki Mano(6), Sara Lonardi(6)